State Ledger
Company profile

PDS Biotechnology Corp CIK 1472091

Ticker
PDSB (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Princeton, NJ 08540
Fiscal year end
2025 (FY)
Market Data
Close
$1.39
Change
+$0.36
Change %
34.30%
Volume
64,482

PDSB · trading date Oct 9, 2026 · previous close $1.04 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$34.50M
Total assets
$30.49M
Total liabilities
$21.24M
Stockholders' equity
$9.25M
Cash & equivalents
$26.71M
Operating income
-$31.54M
Operating cash flow
-$27.75M
Capital expenditures
$0

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$27.75M
Free cash flow margin
—
Liabilities / assets
69.7%
Equity / assets
30.3%
CapEx / revenue
—
Operating cash flow / net income
0.80×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$34.50M $30.49M $21.24M $9.25M
2024 — -$37.61M $45.36M $26.35M $19.00M
2023 — -$42.94M $59.39M $33.26M $26.13M
2022 — -$40.85M $77.01M $33.01M $44.00M
2021 — -$16.92M $67.20M $3.99M $63.21M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 3
2026-09-18
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Princeton, NJ 08540
303A COLLEGE ROAD EAST
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:40 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New Jersey — Public Companies